Cargando…
Rational Design of Novel Anticancer Small-Molecule RNA m6A Demethylase ALKBH5 Inhibitors
[Image: see text] The RNA 6-N-methyladenosine (m6A) demethylase ALKBH5 has been shown to be oncogenic in several cancer types, including leukemia and glioblastoma. We present here the target-tailored development and first evaluation of the antiproliferative effects of new ALKBH5 inhibitors. Two comp...
Autores principales: | Selberg, Simona, Seli, Neinar, Kankuri, Esko, Karelson, Mati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158789/ https://www.ncbi.nlm.nih.gov/pubmed/34056479 http://dx.doi.org/10.1021/acsomega.1c01289 |
Ejemplares similares
-
Small-Molecule Inhibitors of the RNA M6A Demethylases FTO Potently Support the Survival of Dopamine Neurons
por: Selberg, Simona, et al.
Publicado: (2021) -
HIV Replication Is Increased by RNA Methylation METTL3/METTL14/WTAP
Complex Activators
por: Selberg, Simona, et al.
Publicado: (2021) -
Rational Design
and Optimization of m(6)A-RNA
Demethylase FTO Inhibitors as Anticancer Agents
por: Huff, Sarah, et al.
Publicado: (2022) -
RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
por: Qu, Jianwei, et al.
Publicado: (2022) -
Mammalian ALKBH1 serves as an N(6)-mA demethylase of unpairing DNA
por: Zhang, Min, et al.
Publicado: (2020)